Dana dhuwit saben siji saham Actinium Corp (ATNM)

actiniumpharma.com - logo grafis emiten ATNM

Actinium Pharmaceuticals (ATNM) relies on secondary offerings due to a lack of sales, which is confirmed by the liquid position per share trend on the GURU.Markets terminal chart, where the value of 0.90 shows the latest figure. Innovative Iomab-B radioconjugates are undergoing final tests, creating potential for total pricing power through a unique method of tumor irradiation without the use of chemotherapy.

Dhuwit awis saben siji saham Actinium Pharmaceuticals, Inc. (ATNM): kanggo periode 04.07.2022 - 21.11.2026

Rincian analitis perusahaan Actinium Pharmaceuticals, Inc. (ATNM)

- nilai pasar lan prakiraan target analis:
Analisis komprehensif perusahaan:Actinium Pharmaceuticals Inc (ATNM)
Produk mawa merek actiniumpharma.com

This indicator determines the proportion of liquid assets per common share. Analyzing the cash per share allows for an assessment of the issuer's internal financial stability reserve. The metric measures the company's ability to cover operating expenses without incurring external debt. For the pre-revenue business of Actinium Pharmaceuticals (ATNM), this resource is critical for funding costly FDA trials. A decline in this indicator reflects the capital burn rate during the development scaling process.